Latest Tax Incentives News

Delorean Corporation has banked a $5.76 million cash refund from the Australian Government’s FY2025 R&D Tax Incentive, underpinning its bioenergy infrastructure growth. Another refund linked to FY2026 expenditure is anticipated next year.

FirstWave Cloud Technology delivered a strong Q3 FY26 with a $1.40m net operating cash inflow and a major two-year licensing agreement with Mexico’s Banobras bank, marking a key milestone in its AI compliance pivot.

FleetPartners Group Limited reported a 7.3% rise in half-year profit to $37.05 million, driven by lease portfolio growth and the integration of Remunerator. The company declared an 11.9 cent fully franked interim dividend and confirmed a positive outlook for FY26.

Andromeda Metals has secured a $1.66 million cash refund from the Australian Government's R&D Tax Incentive program, reflecting $3.4 million of eligible expenditure tied to its Great White Project.

Brazilian Critical Minerals (ASX: BCM) has locked in pre-approval under Australia’s R&D Tax Incentive for its Ema Rare Earth Project, including critical overseas activities in Brazil. This reduces regulatory uncertainty and supports funding efficiency for advancing the project’s development.

FBR Limited secured its first overseas Mantis welding robot sale, launched the Firehawk refractory robot, and expanded its Wall as a Service footprint in Victoria, while navigating a cash balance under $700,000.

Hastings Technology Metals secures 49% of a Thai hydromet plant, aiming for Q4 2026 production using African monazite feedstock, setting a path for early cash flow ahead of Yangibana.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Environmental Clean Technologies (ASX: ECT) has advanced its PFAS remediation technology with a scalable high-voltage system achieving 1,000°C without additives, expanded its Flash Joule Heating licence to water treatment adsorbents, and formed an expert Advisory Board to accelerate commercialisation.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

Marquee Resources has significantly increased its Mt Clement inferred antimony resource and is advancing drilling and strategic partnerships to develop its flagship project.

Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.